Daniel O'Connell
2022
In 2022, Daniel O'Connell earned a total compensation of $2.7M as President and Chief Executive Officer at Acumen Pharmaceuticals, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $290,865 |
|---|---|
| Option Awards | $1,760,850 |
| Salary | $570,492 |
| Other | $39,845 |
| Total | $2,662,052 |
O'Connell received $1.8M in option awards, accounting for 66% of the total pay in 2022.
O'Connell also received $290.9K in non-equity incentive plan, $570.5K in salary and $39.8K in other compensation.
Rankings
In 2022, Daniel O'Connell's compensation ranked 1,379th out of 5,760 executives tracked by ExecPay. In other words, O'Connell earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,379 out of 5,760 | 76th |
Division Manufacturing | 684 out of 3,136 | 78th |
Major group Chemicals And Allied Products | 258 out of 1,422 | 82nd |
Industry group Drugs | 237 out of 1,323 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 60 out of 291 | 79th |
Source: SEC filing on April 27, 2023.
O'Connell's colleagues
We found two more compensation records of executives who worked with Daniel O'Connell at Acumen Pharmaceuticals in 2022.